ArticleCancer biomarkers : section A of Disease markers2023

Pan-TRK immunohistochemistry as screening tool for NTRK fusions: A diagnostic workflow for the identification of positive patients in clinical practice.

Andrea Vingiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.